The role of novel nicotine-containing products on SARS-CoV-2 infection and COVID-19 progression

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	134-135
Number of pages	2
Journal	European journal of internal medicine
Volume	121
DOIs	https://doi.org/10.1016/j.ejim.2023.12.025
Publication status	Published - Mar 2024

Access to Document

@article{0787c1673c4949eaa6011eca3c7e3565,

title = "The role of novel nicotine-containing products on SARS-CoV-2 infection and COVID-19 progression",

author = "Marco Scala and Alessandra Lugo and Giansanto Mosconi and Antonella Zambon and Anna Odone and Luc Smits and Silvano Gallus",

year = "2024",

month = mar,

doi = "10.1016/j.ejim.2023.12.025",

language = "English",

volume = "121",

pages = "134--135",

journal = "European journal of internal medicine",

issn = "0953-6205",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - The role of novel nicotine-containing products on SARS-CoV-2 infection and COVID-19 progression

AU - Scala, Marco

AU - Lugo, Alessandra

AU - Mosconi, Giansanto

AU - Zambon, Antonella

AU - Odone, Anna

AU - Smits, Luc

AU - Gallus, Silvano

PY - 2024/3

Y1 - 2024/3

U2 - 10.1016/j.ejim.2023.12.025

DO - 10.1016/j.ejim.2023.12.025

M3 - Comment/Letter to the editor

SN - 0953-6205

VL - 121

SP - 134

EP - 135

JO - European journal of internal medicine

JF - European journal of internal medicine

ER -